Priority Date: 16.05.12 (IT 2012CH00008)

USE OF TROP-2 AS PREDICTIVE MARKER OF RESPONSE TO ANTI-TUMOR THERAPY BASED ON INHIBITORS OF CD9, AKT AND MOLECULES OF THE TETRASPANIN SIGNALLING NETWORK

  • Application ID: EP13739819
  • Status: EXAMINATION IN PROGRESS

Attorney

no operation time available
356.37
1 office
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and G01 (MEASURING; TESTING) Isea SRL is specialized in the combination A61 and G01. We found, that Coller IP Management Ltd, TransMIT GmbH, Kailuweit & Uhlemann, Bock Bieber Donath, Dr. Emil Benatov & Partners - Bulgarian Patent Attorney & Licensed Appraiser and 172 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 16.05.2012 - Priority Date (IT 2012CH00008)
  • 21.11.2013 - Publication A2 (WO2013171777)
  • 25.03.2015 - Publication A2 (EP2850433)

IPC Classification